True blood: cutting through confusion about pathology cuts

Bruce Baer Arnold

True blood: cutting through confusion about pathology cuts

Bruce Baer Arnold

Canberra Law School

Research output: Contribution to Newspaper/Magazine/Bulletin › Article

55 Downloads (Pure)

Abstract

The pathology sector in Australia is no longer a cottage industry. It is dominated by a handful of billion-dollar enterprises that analyse blood, tissue and other samples. These tests enable timely diagnosis of a range of illnesses and allow clinicians to optimise treatment by ensuring patients get the right mix of medications for specific conditions.

The sector uses advanced technology, involving high-cost specialist equipment rather than individual pathologists equipped with a microscope. It’s big business. The overall Sonic group, which includes one of the two leading services, last year reported annual revenue of more than A$4 billion.

Original language	English
Pages	1-3
Number of pages	3
Volume	2016
No.	March
Specialist publication	The Conversation
Publisher	The Conversation Paperpress
Publication status	Published - 1 Mar 2016

Access to Document

ArticleFinal published version, 1.2 MBLicence: CC BY-ND

https://theconversation.com/true-blood-cutting-through-confusion-about-pathology-cuts-55140Licence: CC BY-ND

Cite this

@misc{d070e78e984b4226ac9436f982f9a51b,

title = "True blood: cutting through confusion about pathology cuts",

abstract = "The pathology sector in Australia is no longer a cottage industry. It is dominated by a handful of billion-dollar enterprises that analyse blood, tissue and other samples. These tests enable timely diagnosis of a range of illnesses and allow clinicians to optimise treatment by ensuring patients get the right mix of medications for specific conditions. The sector uses advanced technology, involving high-cost specialist equipment rather than individual pathologists equipped with a microscope. It{\textquoteright}s big business. The overall Sonic group, which includes one of the two leading services, last year reported annual revenue of more than A\$4 billion.",

author = "Arnold, \{Bruce Baer\}",

year = "2016",

month = mar,

day = "1",

language = "English",

volume = "2016",

pages = "1--3",

journal = "The Conversation",

issn = "0000-0000",

publisher = "The Conversation Paperpress",

}

TY - GEN

T1 - True blood: cutting through confusion about pathology cuts

AU - Arnold, Bruce Baer

PY - 2016/3/1

Y1 - 2016/3/1

N2 - The pathology sector in Australia is no longer a cottage industry. It is dominated by a handful of billion-dollar enterprises that analyse blood, tissue and other samples. These tests enable timely diagnosis of a range of illnesses and allow clinicians to optimise treatment by ensuring patients get the right mix of medications for specific conditions. The sector uses advanced technology, involving high-cost specialist equipment rather than individual pathologists equipped with a microscope. It’s big business. The overall Sonic group, which includes one of the two leading services, last year reported annual revenue of more than A$4 billion.

AB - The pathology sector in Australia is no longer a cottage industry. It is dominated by a handful of billion-dollar enterprises that analyse blood, tissue and other samples. These tests enable timely diagnosis of a range of illnesses and allow clinicians to optimise treatment by ensuring patients get the right mix of medications for specific conditions. The sector uses advanced technology, involving high-cost specialist equipment rather than individual pathologists equipped with a microscope. It’s big business. The overall Sonic group, which includes one of the two leading services, last year reported annual revenue of more than A$4 billion.

M3 - Article

SN - 0000-0000

VL - 2016

SP - 1

EP - 3

JO - The Conversation

JF - The Conversation

PB - The Conversation Paperpress

ER -

True blood: cutting through confusion about pathology cuts

Abstract

Access to Document

Fingerprint

Cite this